Hongjie Xu, Chengzhi Zhang, Xinyi Zhang, Shuyi Zhang, Guangjun Zhou. Multi-omics single-cell dissection of malignant epithelial heterogeneity identifies GJB2 as an EMT-driving biomarker in triple-negative breast cancer. // BMC Medical Genomics. – 2026. – DOI: 10.1186/s12920-026-02378-7. – URL: https://doi.org/10.1186/s12920-026-02378-7
Hongjie Xu, Chengzhi Zhang, Xinyi Zhang, Shuyi Zhang, & Guangjun Zhou (2026). Multi-omics single-cell dissection of malignant epithelial heterogeneity identifies GJB2 as an EMT-driving biomarker in triple-negative breast cancer. BMC Medical Genomics. https://doi.org/10.1186/s12920-026-02378-7
Hongjie Xu, et al. “Multi-omics single-cell dissection of malignant epithelial heterogeneity identifies GJB2 as an EMT-driving biomarker in triple-negative breast cancer.” BMC Medical Genomics, 2026. doi:10.1186/s12920-026-02378-7.
@article{Xu2026,
title = {Multi-omics single-cell dissection of malignant epithelial heterogeneity identifies GJB2 as an EMT-driving biomarker in triple-negative breast cancer},
author = {Xu, Hongjie and Zhang, Chengzhi and Zhang, Xinyi and Zhang, Shuyi and Zhou, Guangjun},
journal = {BMC Medical Genomics},
year = {2026},
doi = {10.1186/s12920-026-02378-7},
url = {https://doi.org/10.1186/s12920-026-02378-7}
}